Walleye Capital
LJPC

Walleye Capital’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Walleye Capital’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,901
Closed -$69 – 1609
2020
Q4 		$69 Buy
+17,901
New +$76.5K ﹤0.01% 847
2020
Q3 		– Sell
-10,194
Closed -$43K – 1085
2020
Q2 		$43K Sell
10,194
-6,909
-40% -$42.1K 0.01% 550
2020
Q1 		$71K Sell
17,103
-45,908
-73% -$290K 0.02% 648
2019
Q4 		$247K Buy
+63,011
New +$372K 0.02% 1018

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Capital's LJPC Position: Q1 2021 in Review

Walleye Capital sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2021, closing a stake of 17,901 shares — an estimated $69 sold.

Walleye Capital first reported a position in LJPC in Q4 2019 and held it in 4 quarters. The position peaked at $247K in Q4 2019. 76 funds tracked by Wall St. Rank hold LJPC as of Q1 2021.

  • Walleye Capital reported no remaining La Jolla Pharmaceutical Company position as of Q1 2021 after selling out during the quarter.
  • Walleye Capital sold 17,901 La Jolla Pharmaceutical Company shares in Q1 2021, an estimated $69.
  • Walleye Capital first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 4 quarters.
  • Walleye Capital's La Jolla Pharmaceutical Company position peaked at $247K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2021.

Based on Walleye Capital's 13F filing for Q1 2021, filed 17 May 2021.